Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manzoor A Mir

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Cancer Chemotherapy and Pharmacology|January 9, 2021
Tumor microenvironment promotes breast cancer chemoresistanceUmar Mehraj, Abid Hamid Dar, Nissar A Wani, et al.
Medical Oncology (Northwood, London, England)|June 12, 2023
A network pharmacology-based investigation of brugine reveals its multi-target molecular mechanism against Breast CancerHina Qayoom, Mustfa Alkhanani, Abdullah Almilaibary, et al.
Cell Communication and Signaling : CCS|October 10, 2024
Targeting mutant p53: a key player in breast cancer pathogenesis and beyondHina Qayoom, Burhan Ul Haq, Shazia Sofi, et al.
Current Cancer Drug Targets|May 19, 2020
Targeting Different Pathways Using Novel Combination Therapy in Triple Negative Breast CancerManzoor A Mir, Hina Qayoom, Umar Mehraj, et al.
Computational Biology and Chemistry|August 4, 2024
Exploring SALL4 as a significant prognostic marker in breast cancer and its association with progression pathways involved in cancer genesisHina Qayoom, Sania Bashir, Rumaisa Khan, et al.
Discover Oncology|April 13, 2026
Cytochrome c as a central regulator of mitochondrial function in cancer metabolismAisha Shabir, Shazia Sofi, Nusrat Jan, et al.
Current Pharmaceutical Biotechnology|July 1, 2020
Development of New Therapeutics to Meet the Current Challenge of Drug Resistant TuberculosisBashir A Sheikh, Basharat A Bhat, Umar Mehraj, et al.
Medical Oncology (Northwood, London, England)|April 29, 2022
Cyclin-dependent kinases in breast cancer: expression pattern and therapeutic implicationsShazia Sofi, Umar Mehraj, Hina Qayoom, et al.
Journal of Biomedical Nanotechnology|January 3, 2022
Nano-Drug Delivery Systems: Possible End to the Rising Threats of TuberculosisBashir A Sheikh, Basharat A Bhat, Bader Alshehri, et al.
Frontiers in Pharmacology|January 25, 2024
Targeting p53 misfolding conundrum by stabilizing agents and their analogs in breast cancer therapy: a comprehensive computational analysisBurhan Ul Haq, Hina Qayoom, Shazia Sofi, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Cancer Chemotherapy and Pharmacology|January 9, 2021
Tumor microenvironment promotes breast cancer chemoresistanceUmar Mehraj, Abid Hamid Dar, Nissar A Wani, et al.
Medical Oncology (Northwood, London, England)|June 12, 2023
A network pharmacology-based investigation of brugine reveals its multi-target molecular mechanism against Breast CancerHina Qayoom, Mustfa Alkhanani, Abdullah Almilaibary, et al.
Cell Communication and Signaling : CCS|October 10, 2024
Targeting mutant p53: a key player in breast cancer pathogenesis and beyondHina Qayoom, Burhan Ul Haq, Shazia Sofi, et al.
Current Cancer Drug Targets|May 19, 2020
Targeting Different Pathways Using Novel Combination Therapy in Triple Negative Breast CancerManzoor A Mir, Hina Qayoom, Umar Mehraj, et al.
Computational Biology and Chemistry|August 4, 2024
Exploring SALL4 as a significant prognostic marker in breast cancer and its association with progression pathways involved in cancer genesisHina Qayoom, Sania Bashir, Rumaisa Khan, et al.
Discover Oncology|April 13, 2026
Cytochrome c as a central regulator of mitochondrial function in cancer metabolismAisha Shabir, Shazia Sofi, Nusrat Jan, et al.
Current Pharmaceutical Biotechnology|July 1, 2020
Development of New Therapeutics to Meet the Current Challenge of Drug Resistant TuberculosisBashir A Sheikh, Basharat A Bhat, Umar Mehraj, et al.
Medical Oncology (Northwood, London, England)|April 29, 2022
Cyclin-dependent kinases in breast cancer: expression pattern and therapeutic implicationsShazia Sofi, Umar Mehraj, Hina Qayoom, et al.
Journal of Biomedical Nanotechnology|January 3, 2022
Nano-Drug Delivery Systems: Possible End to the Rising Threats of TuberculosisBashir A Sheikh, Basharat A Bhat, Bader Alshehri, et al.
Frontiers in Pharmacology|January 25, 2024
Targeting p53 misfolding conundrum by stabilizing agents and their analogs in breast cancer therapy: a comprehensive computational analysisBurhan Ul Haq, Hina Qayoom, Shazia Sofi, et al.
Pageof 3